Latest stories
Fully informed consent must be respected, especially in the age of AI
Governance
This part of an AI governance series, which began with data handling, focuses on informed consent, which must legally be obtained from users but, too often, companies follow the letter of the law, not the spirit, says Benedictine University applied AI researcher Prof Todd Kelsey.
Todd Kelsey  |  Oct 03 , 2023
AI is humanity’s best chance to even the climate playing field
Game-changers
The world is likely to miss its target of limiting global warming to 1.5°C above pre-industrial temperatures, with potentially serious consequences. Business as usual is not an option, which means that AI must play a big role for humanity to avoid the worst of climate change.
Maxwell Gomera  |  Oct 02 , 2023
Sepsis and machine learning-driven clinical decision support tools
Domain knowledge
ML may augment clinical support for potentially deadly immune reactions due to sepsis. To devise, test, and implement clinical support tools in clinical practice is arduous, but common denominators from successful use may apply to other severe conditions. Medical and analytics researcher Matthew Marcetich reports.
Matthew Marcetich  |  Sep 29 , 2023
ChiefAIOfficer.com underscores the necessity of a head of AI
Generic
Many companies have CEOs, CFOs, and COOs, but for them to have also chief AI officers is equally important nowadays. This is true above all because most companies report they have not yet been able to fully exploit the benefits of AI. Tech writer Priya Dialani elaborates.
Priya Dialani  |  Sep 28 , 2023
Mercedes-Benz case study illustrates the impact of 5G and B5G on AVs
New era
5G technology is now ubiquitous, but its applications extend beyond mobile networks. AVs are one example and 5G and its successors will be a big reason why if they ever become mainstream, says Purva Joshi, a PhD candidate in Healthtech at the University of Pisa.
Purva Joshi  |  Sep 27 , 2023
Ethics and AI in medicine: Essentials every modern doctor should know
Cognition
This second in a two-part series covers the most important considerations that doctors and other medical professionals should be aware of as AI and other new tech increasingly integrate into the healthcare terrain. AI and ML engineer and medical doctor Sahika Betul Yayli lays it out in plain terms.
Sahika Betul Yayli  |  Sep 26 , 2023
AI digital twin ocean tech to help Nigeria cope with natural disasters
Game-changers
Nigeria is a vast, complex country facing myriad challenges, not the least of which are climate-induced and other natural disasters, but new tech is in the works that can help model and predict nature’s fury and cushion its impact. ML engineer Jacia Ebubechi gives the lowdown.
Jacia Ebubechi  |  Sep 25 , 2023
AI, predictive analytics deploy to spot, prevent employee burnout
Generic
AI obsoleting human jobs prompts much handwringing but overwork and employee burnout are even more urgent problems. If AI eases the load for overburdened workers, this will thus be a welcome development, states Vasily Malyshev, attorney and founder of HR software maker Intelogos.
Vasily Malyshev  |  Sep 22 , 2023
AI adjudication, legislation around the corner as ‘legal singularity’ looms
Generic
The ‘legal singularity’ refers to the law becoming a solved problem, with machines able to predict the outcome of any potential lawsuit such that no cases ever reach court. Best-selling AI author Calum Chace cites law professor Ben Alarie to describe the implications of all this.
Calum Chace  |  Sep 21 , 2023
AI supercharges biomarker-driven clinical trials, raises accuracy, success
Optimization
Clinical trials are key in testing new treatments and their suitability for widespread use. AI is already making drug discovery cheaper and more efficient, and is now boosting clinical trials’ success. Pharma analyst and BiopharmaTrend.com co-founder Andrii Buvailo reports.
Andrii Buvailo  |  Sep 20 , 2023
Community More+
Janna Lipenkova
Janna Lipenkova
Janna Lipenkova is a computational linguist who speaks seven languages. She heads two companies, Anacode and Equintel, that use AI to deliver cutting-edge business intelligence and guide clients towards smarter decisions, strategy, and execution.
Philip M. Parker
Philip M. Parker
Philip M. Parker is Professor of Marketing at INSEAD and the INSEAD Chaired Professor of Management Science.His research explores why existing theories governing macroeconomic growth and firm level competition yield unreliable forecasts of actual market outcomes. He introduced the idea that physical sciences should be directly integrated into macroeconomic studies.
Ganes Kesari
Ganes Kesari
Ganes Kesari is an entrepreneur, AI thought leader, author, adjunct professor, and TEDx speaker. He is the founder of Innovation Titan, a data-science thought leadership and advisory firm. He advises executives on data-driven leadership and helps organizations adopt a culture of data for decision-making.
Johannes Walter
Johannes Walter
Johannes Walter is head of department and scientific director of digitalization and digital association development at Diakonie Baden as well as associate professor at IU International University of Applied Sciences. His research focuses on AI in healthcare and digital transformation in the social and healthcare sector.
Nikolaj van Omme
Nikolaj van Omme
Nikolaj van Omme is chief executive officer of Funartech, an AI startup that provides creative solutions to complex industrial problems by combining machine learning and applied mathematics. He is a strong proponent of hybrid methods and approaches, in particular the hybridization of machine learning and operations research.
Shanen Boettcher
Shanen Boettcher
Shanen Boettcher is a former General Manager of Microsoft’s Startup Business Group, which oversees the innovation of Microsoft’s core businesses. He also holds a PhD in human-machine communication and AI from the University of St Andrews, and has experience operationalizing strategy, developing global award-winning products, building tools and guidance for high-tech startups at Responsible Innovation Labs, and working as a product strategist for AI21 Labs, a leading artificial intelligence and large language model startup.
Austin Lentsch
Austin Lentsch
Austin Lentsch is a policy fellow at MIT’s Blueprint Labs.
Tonny Huang
Tonny Huang
Manager at Kearney.
Betty Pio
Betty Pio
Partner at Kearney.
Keena Patel-Moran
Keena Patel-Moran
Partner at Kearney.